Volunteers are being sought to provide blood samples for a new COVID-19 antibody test study approved by an IRB. Eligible adult volunteers must meet at least one criteria such as never having COVID-19, having recovered from it, not being vaccinated or being vaccinated. Participants will sign a consent form, fill out a questionnaire, and provide blood samples to help develop the new test measuring neutralizing antibodies against COVID-19.
Volunteers are being sought to provide blood samples for a new COVID-19 antibody test study approved by an IRB. Eligible adult volunteers must meet at least one criteria such as never having COVID-19, having recovered from it, not being vaccinated or being vaccinated. Participants will sign a consent form, fill out a questionnaire, and provide blood samples to help develop the new test measuring neutralizing antibodies against COVID-19.
Volunteers are being sought to provide blood samples for a new COVID-19 antibody test study approved by an IRB. Eligible adult volunteers must meet at least one criteria such as never having COVID-19, having recovered from it, not being vaccinated or being vaccinated. Participants will sign a consent form, fill out a questionnaire, and provide blood samples to help develop the new test measuring neutralizing antibodies against COVID-19.
Mar 31, 2021 20200806 We are seeking volunteers to help us develop a new test to measure neutralizing #30430224.0
antibodies against the COVID-19 virus. Volunteers must be willing to provide a
blood sample and will gain knowledge on the COVID-19 antibody status. Volunteer must be adults (18 years of age or older) who meet any on the following criteria: • Have never been diagnosed with COVID-19 • Have previously had and recovered from COVID-19 • Have not yet received or are planning to receive a COVID-19 vaccine • Have received a COVID-19 vaccine Eligible participants will: • Sign a consent form explaining the study and requirements • Complete a brief questionnaire • Provide blood samples
For additional information, please contact:
Donna Sellers (Clinical Research Coordinator) Tel: 229-315-6749 | Email: CRC@vyriad.com